CompanyGraph
What stands out
- Earnings significantly exceed cash generation
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- PositionDebt-to-equity is 0×, lower than 95% of its Diagnostics & Research peers (median 0.15×)
- FinancialsAltman Z-Score 8.94: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.38%
Annual Rate
CNY 0.16Paid semi-annual
Payout Ratio
9.4%Sustainable
Last Ex-Dividend
Jul 9, 2026
The reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
Financials view
Market Capitalization
3.13BCNY467.79M · vs all stocks (USD)
Trailing P/E
55.11xvs Diagnostics & Research peers
Revenue (TTM)
824.77MCNY123.07M · vs all stocks (USD)
Profit Margin
7.04%vs Diagnostics & Research peers
Beta
0.8630xvs all stocks
52-Week Change
-15.25%vs all stocks
Forward Annual Dividend Yield
0.38%vs all stocks
Market Capitalization
3.13BCNY467.79M · vs all stocks (USD)
Enterprise Value
2.56BCNY382.21M · vs all stocks (USD)
Trailing P/E
55.11xvs Diagnostics & Research peers
Forward P/E
26.50xvs Diagnostics & Research peers
Price to Sales (TTM)
3.80xvs Diagnostics & Research peers
Price to Book (MRQ)
2.48xvs Diagnostics & Research peers
Enterprise to Revenue
3.11xvs Diagnostics & Research peers
Enterprise to EBITDA
57.97xvs Diagnostics & Research peers
Profit Margin
7.04%vs Diagnostics & Research peers
Operating Margin
-17.58%vs Diagnostics & Research peers
Return on Assets (TTM)
1.58%vs Diagnostics & Research peers
Return on Equity (TTM)
4.67%vs Diagnostics & Research peers
Revenue (TTM)
824.77MCNY123.07M · vs all stocks (USD)
Revenue per Share (TTM)
9.89CNYUpdated Sep 21, 2026Quarterly Revenue Growth
-16.50%vs Diagnostics & Research peers
Gross Profit (TTM)
164.10MCNY24.49M · vs all stocks (USD)
EBITDA (TTM)
159.62MCNY23.82M · vs all stocks (USD)
Net Income (TTM)
58.07MCNY8.67M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
1.06%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
13.31MCNY1.99M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-32.38MCNY-4.83M · vs all stocks (USD)
Forward Annual Dividend Rate
0.1600CNYUpdated Sep 21, 2026Forward Annual Dividend Yield
0.38%vs all stocks
Trailing Annual Dividend Rate
0.1480CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.36%vs all stocks
Payout Ratio
9.44%vs Diagnostics & Research peers
Revenue
842.50MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
624.56MCNYFY2025 · Dec 31, 2025Gross Profit
217.95MCNYFY2025 · Dec 31, 2025Operating Income
134.34MCNY20.05M · vs all stocks (USD)
Pre-tax Income
127.88MCNYFY2025 · Dec 31, 2025Income Tax Expense
18.24MCNYFY2025 · Dec 31, 2025Net Income
109.64MCNYFY2025 · Dec 31, 2025EBIT
128.08MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
159.62MCNYFY2025 · Dec 31, 2025Research & Development
38.77MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
8.35MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.72MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.57MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
200.75KCNYFY2025 · Dec 31, 2025EPS (Basic)
1.38CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.38CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
79.45MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
79.45MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
109.64MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-19.58MCNYFY2025 · Dec 31, 2025Free Cash Flow
-27.20MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
467.28MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
109.64MCNYFY2025 · Dec 31, 2025Other Non-cash Items
-335.40KCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-130.25MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
1.36MCNYFY2025 · Dec 31, 2025Capital Expenditures
-7.62MCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.08BCNYFY2025 · Dec 31, 2025Sale of Investments
4.18BCNYFY2025 · Dec 31, 2025Other Investing Activity
-89.36MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-2.20MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-13.32MCNYFY2025 · Dec 31, 2025Other Financing Charges
-41.88MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-55.20MCNYFY2025 · Dec 31, 2025Shares Outstanding
79.00MSharesUpdated Sep 21, 2026Float Shares
46.75MSharesUpdated Sep 21, 2026% Held by Insiders
43.19%vs all stocks
% Held by Institutions
16.24%vs all stocks
Total Cash (MRQ)
576.93MCNY86.09M · vs all stocks (USD)
Total Cash per Share (MRQ)
7.30CNYUpdated Sep 21, 2026Total Debt (MRQ)
3.38MCNY504.92K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0027xvs Diagnostics & Research peers
Current Ratio (MRQ)
4.62xvs Diagnostics & Research peers
Book Value per Share (MRQ)
16.02CNYUpdated Sep 21, 2026Total Assets
1.54BCNY230.38M · vs all stocks (USD)
Total Current Assets
1.32BCNYFY2025 · Dec 31, 2025Total Liabilities
274.41MCNYFY2025 · Dec 31, 2025Total Non-current Assets
222.38MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
612.07KCNYFY2025 · Dec 31, 2025Total Current Liabilities
273.80MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
467.28MCNYFY2025 · Dec 31, 2025Other Short-term Investments
150.31MCNYFY2025 · Dec 31, 2025Accounts Receivable
169.47MCNYFY2025 · Dec 31, 2025Accounts Payable
13.01MCNYFY2025 · Dec 31, 2025Short-term Debt
3.71MCNYFY2025 · Dec 31, 2025Other Current Liabilities
22.38MCNYFY2025 · Dec 31, 2025Long-term Debt
611.39KCNYFY2025 · Dec 31, 2025Common Stock (Book)
79.00MCNYFY2025 · Dec 31, 2025Retained Earnings
503.53MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.27BCNY189.44M · vs all stocks (USD)
52-Week Low
34.49CNYUpdated Sep 21, 202652-Week High
85.00CNYUpdated Sep 21, 202652-Week Change
-15.25%vs all stocks
Beta
0.8630xvs all stocks
50-Day MA
44.89CNYUpdated Sep 21, 2026200-Day MA
52.88CNYUpdated Sep 21, 2026Avg 10-Day Volume
4.04MSharesUpdated Sep 21, 2026Avg 30-Day Volume
5.10MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.7200CNYUpdated Sep 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 0×, lower than 95% of its Diagnostics & Research peers (median 0.15×)Notable
Debt-to-equity: 0.00Industry median: 0.15Industry P5: 0.01Peers compared: 30.00
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 8,665,787.358Operating Cash Flow (USD, TTM): 1,985,403.287
Financial Health
Altman Z-Score 8.94: safe zoneNotable
Altman Z-Score: 8.94
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Venus Pipes & Tubes Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Xinjiang Tianshan Animal Husbandry Bio-Engineering Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRisk
Jinlong Machinery & Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRisk
Shenyang Yuanda Intellectual Industry Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Changzhou Wujin Zhongrui Electric Appliance Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Pack Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Forest Packaging Group Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
SmartGen Zhengzhou Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Bluesword Intelligent Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Ningxia Xiaoming Agriculture & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Hubei Xiangyuan New Material Co., Ltd.
3 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Xiamen Voke Mold & Plastic Co., Ltd.
3 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration
Wcon Electronics Guangdong Co., Ltd.
3 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration